IBSA USA
Jarrid Spiegel serves as the Regional Sales Manager for the Southwest at IBSA Pharma Inc. since September 2021, bringing a wealth of experience in sales and management within the pharmaceutical industry. Prior roles include Director of Sales at WALTLabs.io, Regional Business Manager at ALK, and Regional Business Director (Vision Care) at Bausch + Lomb. Jarrid also has experience as a Clinical Sales Specialist at Ironwood Pharmaceuticals and Regional Sales Manager at Valeant Pharmaceuticals. Earlier in their career, Jarrid held positions such as District Sales Manager at Meda Pharmaceuticals, Specialty Sales Representative at Novartis, and Account Manager at Allegis Group. Jarrid Spiegel earned a Bachelor of Business Administration with a focus in Marketing from Hofstra University.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.